NRX PHARMACEUTICALS
NRx Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics for the treatment of central nervous system disorders and pulmonary diseases. It addresses life-threatening diseases that often go untreated by researching, developing, and scaling solutions to help people who most desperately need them. The company has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure, and is also developing NRX-100/101 which is the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. In July 2021, the Government of Israel awarded NRx the exclusive worldwide right to develop and market the BriLifeR COVID vaccine developed by the Israel Institute for Biological Research.
NRX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.nrxpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 484.254.6134
Email Addresses:
[email protected]
Total Funding:
80.8 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Microsoft Azure DNS GoDaddy DNS GoDaddy Email Fastly Hosted Fastly Load Balancer SMTP.com
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Curidium Medica
Curidium Medica identifies medicines and companion diagnostics for the treatment of central nervous system disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kinled Holding
Kinled Holding investment in Series C - NRx Pharmaceuticals
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.nrxpharma.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.06 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
